Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia

被引：40

作者：

Chanda P. ^{[1
]}

Castillo-Riquelme M. ^{[2
]}

Masiye F. ^{[3
]}

机构：

[1] National Malaria Control Centre, Lusaka

[2] Health Economics Unit, Department of Public Health and Family Medicine, University of Cape Town, Cape Town

[3] Department of Economics, University of Zambia, Lusaka

来源：

Cost Effectiveness and Resource Allocation | / 7卷 / 1期

关键词：

Malaria; Malaria Case; Uncomplicated Malaria; Artemether; Malaria Diagnosis;

D O I：

10.1186/1478-7547-7-5

中图分类号：

学科分类号：

摘要：

Background: Malaria in Zambia accounts for about 4 million clinical cases and 8 000 deaths annually. Artemether-lumefantrine (ACT), a relatively expensive drug, is being used as first line treatment of uncomplicated malaria. However, diagnostic capacity in Zambia is low, leading to potentially avoidable wastage of drugs due to unnecessary anti malarial treatment. Methods: A cost-effectiveness evaluation of the three current alternatives to malaria diagnosis (clinical, microscopy and Rapid Diagnostic Tests- RDT) was conducted in 12 facilities from 4 districts in Zambia. The analysis was conducted along an observational study, thus reflecting practice in health facilities under routine conditions. Average and incremental cost effectiveness ratios were estimated from the providers' perspective. Effectiveness was measured in relation to malaria cases correctly diagnosed by each strategy. Results: Average cost-effectiveness ratios show that RDTs were more efficient (US$ 6.5) than either microscopy (US$ 11.9) or clinical diagnosis (US$ 17.1) for malaria case correctly diagnosed. In relation to clinical diagnoses the incremental cost per case correctly diagnosed and treated was US$ 2.6 and US$ 9.6 for RDT and microscopy respectively. RDTs would be much cheaper to scale up than microscopy. The findings were robust to changes in assumptions and various parameters. Conclusion: RDTs were the most cost effective method at correctly diagnosing malaria in primary health facilities in Zambia when compared to clinical and microscopy strategies. However, the treatment prescription practices of the health workers can impact on the potential that a diagnostic test has to lead to savings on antimalarials. The results of this study will serve to inform policy makers on which alternatives will be most efficient in reducing malaria misdiagnosis by taking into account both the costs and effects of each strategy. © 2009 Chanda et al; licensee BioMed Central Ltd.

引用

共 27 条

[1]

WHO Technical Report Series, No. 892 Twentieth Report. Geneva, (2000)

[2]

World Malaria Report. Geneva, (2005)

[3]

Malaria Situation Analysis. Lusaka, (2000)

[4]

Omari A., Preston C., Garner P., Artemether-lumefantrine for treating uncomplicated falciparum malaria, Cochrane Database of Systematic Reviews, 2, (2002)

[5]

Chanda P., Sikaala C.H., Kapelwa W., Moonga H., Njunju E., Macdonald M., Thea D., Hamer D.H., Sipilanyambe N., Assesment of the therapeutic efficacy of artemether-lumefantrine (Coartem®) and sulphadoxine-pyrimethamine (SP)-artesunate in Zambian children, 53rd Annual Meeting of the Society of Tropical Medicine and Hygiene 7 - 11 November, 2004, Miami, FL. Abstract 213, (2004)

[6]

Roll Back Malaria Baseline Survey. Lusaka, (2000)

[7]

Gove S., Integrated management of childhood illness by out-patients health workers: Technical basis and overview, Bull World Health Organ, 75, pp. 7-24, (1997)

[8]

Chandramohan D., Jaffar S., Greenwood B., Use of clinical algorithms for diagnosing malaria, Trop Med Int Health, 7, pp. 45-52, (2002)

[9]

Roll Back Malaria Baseline Survey. Lusaka, (2005)

[10]

Hanscheid T., Current strategies to avoid misdiagnosis of malaria, Clin Microbiol Infect, 9, pp. 497-504, (2003)

← 1 2 3 →